Literature DB >> 16125145

Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.

Eva Elgh1, Ann Lindqvist Astot, Markku Fagerlund, Sture Eriksson, Tommy Olsson, Birgitta Näsman.   

Abstract

BACKGROUND: The hippocampal formation is damaged early in Alzheimer's disease (AD). An association between temporal lobe volume and cognitive function has been shown in several studies. Increased limbic-hypothalamic-pituitary-adrenal (LHPA) axis function has been suggested to be related to hippocampal atrophy and cognitive impairment. Our hypothesis was that there is a clear link between hippocampal volume -- notably of the CA1 region -- memory (episodic and visuospatial) and decreased feedback sensitivity in the LHPA axis in AD.
METHODS: Sixteen medication-free outpatients with mild to moderate AD were included. Hippocampal volume was measured with magnetic resonance imaging. Dexamethasone suppression tests were performed using .5 mg and .25 mg dexamethasone. Three different components in the neuropsychological battery -- Rey 15 item memory test, Alzheimer's Disease Assessment Scale (ADAS) word recall and spatial span from Wechsler Adult Intelligence Scale - Revised neuropsychological instrument (WAIS-R NI) -- were found to represent episodic and visuospatial memory.
RESULTS: Low hippocampal CA1 volume and high post-dexamethasone cortisol levels in combination were significantly associated with Rey 15 item memory and spatial span test outcomes. No association was found between LHPA feedback and hippocampal volume.
CONCLUSIONS: Low hippocampal volume and a disturbed negative feedback in the LHPA axis link to specific cognitive impairments in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125145     DOI: 10.1016/j.biopsych.2005.06.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  46 in total

1.  Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease.

Authors:  Maite Solas; Bárbara Aisa; María C Mugueta; Joaquín Del Río; Rosa M Tordera; María J Ramírez
Journal:  Neuropsychopharmacology       Date:  2010-02-24       Impact factor: 7.853

2.  Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.

Authors:  Fabien Lanté; Magda Chafai; Elisabeth Fabienne Raymond; Ana Rita Salgueiro Pereira; Xavier Mouska; Scherazad Kootar; Jacques Barik; Ingrid Bethus; Hélène Marie
Journal:  Neuropsychopharmacology       Date:  2015-01-27       Impact factor: 7.853

3.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Enhanced Hypothalamic NMDA Receptor Activity Contributes to Hyperactivity of HPA Axis in Chronic Stress in Male Rats.

Authors:  Jing-Jing Zhou; Yonggang Gao; Xiangjian Zhang; Therese A Kosten; De-Pei Li
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

5.  Effects of glucocorticoids on age-related impairments of hippocampal structure and function in mice.

Authors:  Wen-Bin He; Jun-Long Zhang; Jin-Feng Hu; Yun Zhang; Takeo Machida; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

Review 6.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Membrane-Associated Effects of Glucocorticoid on BACE1 Upregulation and Aβ Generation: Involvement of Lipid Raft-Mediated CREB Activation.

Authors:  Gee Euhn Choi; Sei-Jung Lee; Hyun Jik Lee; So Hee Ko; Chang Woo Chae; Ho Jae Han
Journal:  J Neurosci       Date:  2017-08-03       Impact factor: 6.167

9.  Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology.

Authors:  David Baglietto-Vargas; Rodrigo Medeiros; Hilda Martinez-Coria; Frank M LaFerla; Kim N Green
Journal:  Biol Psychiatry       Date:  2013-01-08       Impact factor: 13.382

10.  Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons.

Authors:  Alexis M Stranahan; Thiruma V Arumugam; Roy G Cutler; Kim Lee; Josephine M Egan; Mark P Mattson
Journal:  Nat Neurosci       Date:  2008-02-17       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.